SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-06-13 17:43
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Gover, Justin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		43,542
Filed 2024-06-13 17:37
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Cannon, Gillian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		43,542
Filed 2024-06-07 14:56
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		110,661
Filed 2024-06-07 14:52
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		68,517
Filed 2024-06-07 14:46
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		112,103
Filed 2024-06-07 14:28
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Machado, Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		82,017
Filed 2024-06-07 14:21
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		114,161
Filed 2024-03-13 17:55
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-7,407 vol 		433,500
Filed 2024-03-13 17:55
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-1,234 vol 		440,907
Filed 2024-03-13 17:55
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-283,263.40
-6,118 vol
$46.30 each 		8,398
Filed 2024-03-13 17:54
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,026.85
-1,019 vol
$46.15 each 		14,516
Filed 2024-03-13 17:54
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,242.44
-1,289 vol
$45.96 each 		15,535
Filed 2024-03-13 17:53
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$72,958
+7,407 vol
$9.85 each 		16,824
Filed 2024-03-13 17:53
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,881.40
-215 vol
$45.96 each 		9,417
Filed 2024-03-13 17:52
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,154
+1,234 vol
$9.85 each 		9,632
Filed 2024-03-13 17:50
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-92,402.40
-2,000 vol
$46.20 each 		2,000
Filed 2024-03-13 17:50
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,512.50
-5,000 vol
$46.30 each 		4,000
Filed 2024-03-13 17:50
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,250
-5,000 vol
$46.25 each 		9,000
Filed 2024-03-13 17:49
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-46,450
-1,000 vol
$46.45 each 		14,000
Filed 2024-03-13 17:40
Tx date 2024-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,500 vol 		52,975
Filed 2024-03-13 17:36
Tx date 2024-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-95,583.48
-2,092 vol
$45.69 each 		0
Filed 2024-03-13 17:34
Tx date 2024-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-64,993.28
-1,408 vol
$46.16 each 		2,092
Filed 2024-03-13 17:33
Tx date 2024-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$64,959
+3,500 vol
$18.56 each 		3,500
Filed 2024-03-13 17:25
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-03-13 17:16
Tx date 2024-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,500 vol
Filed 2024-03-12 19:17
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-92,402.40
-2,000 vol
$46.20 each
Filed 2024-03-12 19:16
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,512.50
-5,000 vol
$46.30 each
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,250
-5,000 vol
$46.25 each
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-46,450
-1,000 vol
$46.45 each
Filed 2024-03-11 17:07
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-7,407 vol
Filed 2024-03-11 17:06
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-1,234 vol
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-283,263.40
-6,118 vol
$46.30 each
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,026.85
-1,019 vol
$46.15 each
Filed 2024-03-11 17:01
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,242.44
-1,289 vol
$45.96 each
Filed 2024-03-11 17:00
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$72,958
+7,407 vol
$9.85 each
Filed 2024-03-11 16:59
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,881.40
-215 vol
$45.96 each
Filed 2024-03-11 16:58
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,154
+1,234 vol
$9.85 each
Filed 2024-03-12 19:17
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-92,402.40
-2,000 vol
$46.20 each 		2,000
Filed 2024-03-12 19:16
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,512.50
-5,000 vol
$46.30 each 		4,000
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,250
-5,000 vol
$46.25 each 		9,000
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-46,450
-1,000 vol
$46.45 each 		14,000
Filed 2024-03-11 17:07
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-7,407 vol 		433,500
Filed 2024-03-11 17:06
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-1,234 vol 		440,907
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-283,263.40
-6,118 vol
$46.30 each 		8,398
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,026.85
-1,019 vol
$46.15 each 		14,516
Filed 2024-03-11 17:01
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,242.44
-1,289 vol
$45.96 each 		15,535
Filed 2024-03-11 17:00
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$72,958
+7,407 vol
$9.85 each 		16,824
Filed 2024-03-11 16:59
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,881.40
-215 vol
$45.96 each 		9,417
Filed 2024-03-11 16:58
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,154
+1,234 vol
$9.85 each 		9,632
Filed 2024-03-11 16:49
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-283,263.40
-6,118 vol
$46.30 each
Filed 2024-03-11 16:49
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-47,026.85
-1,019 vol
$46.15 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-59,242.44
-1,289 vol
$45.96 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$72,958
+7,407 vol
$9.85 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-9,881.40
-215 vol
$45.96 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$12,154
+1,234 vol
$9.85 each
Filed 2024-03-11 15:30
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-283,263.40
-6,118 vol
$46.30 each
Filed 2024-03-11 15:30
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-283,263.40
-6,118 vol
$46.30 each 		442,141
Filed 2024-03-11 15:26
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-47,026.85
-1,019 vol
$46.15 each 		448,259
Filed 2024-03-11 15:26
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-47,026.85
-1,019 vol
$46.15 each
Filed 2024-03-11 15:25
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-59,242.44
-1,289 vol
$45.96 each
Filed 2024-03-11 15:25
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-59,242.44
-1,289 vol
$45.96 each 		449,278
Filed 2024-03-11 15:24
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$72,958
+7,407 vol
$9.85 each
Filed 2024-03-11 15:24
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$72,958
+7,407 vol
$9.85 each 		450,567
Filed 2024-03-11 15:21
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-9,881.40
-215 vol
$45.96 each
Filed 2024-03-11 15:21
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-9,881.40
-215 vol
$45.96 each 		443,160
Filed 2024-03-11 15:19
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$12,154
+1,234 vol
$9.85 each
Filed 2024-03-11 15:19
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$12,154
+1,234 vol
$9.85 each 		443,375
Filed 2024-01-03 13:24
Tx date 2023-12-29 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-8,398 vol 		8,398
Filed 2023-12-20 17:57
Tx date 2023-12-19 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$37,697
+3,497 vol
$10.78 each 		74,225
Filed 2023-12-20 17:55
Tx date 2023-12-19 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-37,697.66
-3,497 vol
$10.78 each 		101,705
Filed 2023-12-20 17:52
Tx date 2023-12-19 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,871
+823 vol
$10.78 each 		70,728
Filed 2023-12-20 17:50
Tx date 2023-12-19 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-8,871.94
-823 vol
$10.78 each 		105,202
Filed 2023-12-18 15:46
Tx date 2023-12-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-311,897.90
-7,598 vol
$41.05 each 		4,902
Filed 2023-12-18 15:41
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-158,443.68
-3,977 vol
$39.84 each 		23,573
Filed 2023-12-18 15:39
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$35,793
+3,977 vol
$9.00 each 		27,550
Filed 2023-12-18 15:35
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-12,580.26
-1,167 vol
$10.78 each 		96,561
Filed 2023-12-18 15:33
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-42,872.06
-3,977 vol
$10.78 each 		97,728
Filed 2023-12-18 15:29
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-90,047.30
-2,303 vol
$39.10 each 		23,573
Filed 2023-12-18 15:28
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,826
+2,303 vol
$10.78 each 		25,876
Filed 2023-12-18 15:27
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-22,895.36
-577 vol
$39.68 each 		101,705
Filed 2023-12-18 15:24
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-24,826.34
-2,303 vol
$10.78 each 		102,282
Filed 2023-12-18 15:19
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-198,594
-5,100 vol
$38.94 each 		23,573
Filed 2023-12-18 15:12
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$54,978
+5,100 vol
$10.78 each 		28,673
Filed 2023-12-18 15:06
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-13,776.84
-1,278 vol
$10.78 each 		104,585
Filed 2023-12-18 14:54
Tx date 2023-12-13 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-54,978
-5,100 vol
$10.78 each 		105,863
Filed 2023-08-24 16:45
Tx date 2023-08-24 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-967,500
-25,000 vol
$38.70 each 		25,000
Filed 2023-08-10 19:41
Tx date 2023-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Gover, Justin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+28,000 vol 		28,000
Filed 2023-08-10 19:39
Tx date 2023-08-08 		$XENE
Xenon Pharmaceuticals Inc. 		Gover, Justin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-10 19:30
Tx date 2023-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Cannon, Gillian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+28,000 vol 		28,000
Filed 2023-08-10 19:28
Tx date 2023-08-08 		$XENE
Xenon Pharmaceuticals Inc. 		Cannon, Gillian
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-05 13:35
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		56,475
Filed 2023-06-05 13:33
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Machado, Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		66,475
Filed 2023-06-05 13:31
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		106,025
Filed 2023-06-05 13:30
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		1,218,157
Filed 2023-06-05 13:28
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		110,963
Filed 2023-06-05 13:26
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		98,619
Filed 2023-06-05 13:24
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		95,119
Filed 2023-06-02 18:02
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-940,608.90
-24,255 vol
$38.78 each 		6,000
Filed 2023-06-02 18:01
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-799,304.85
-20,745 vol
$38.53 each 		30,255
Filed 2023-06-02 17:59
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$799,200
+45,000 vol
$17.76 each 		51,000
Filed 2023-06-02 17:58
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-799,200
-45,000 vol
$17.76 each 		1,199,682
Filed 2023-06-02 17:56
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-290,638.26
-7,458 vol
$38.97 each 		6,000
Filed 2023-06-02 17:55
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$-71,665.80
-1,860 vol
$38.53 each 		13,458
Filed 2023-06-02 17:49
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-71,655.42
-9,318 vol
$7.69 each 		1,244,682
Filed 2023-06-02 17:46
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$71,655
+9,318 vol
$7.69 each 		15,318
Filed 2023-06-02 17:45
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,039,058.64
-26,856 vol
$38.69 each 		6,000
Filed 2023-06-02 17:42
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$-888,035.28
-23,144 vol
$38.37 each 		32,856
Filed 2023-06-02 17:41
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$888,000
+50,000 vol
$17.76 each 		56,000
Filed 2023-06-02 17:39
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-888,000
-50,000 vol
$17.76 each 		1,254,000
Filed 2023-06-02 17:34
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-918,632.70
-23,670 vol
$38.81 each 		6,000
Filed 2023-06-02 17:32
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$-236,551.05
-6,165 vol
$38.37 each 		29,670
Filed 2023-06-02 17:29
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$293,874
+29,835 vol
$9.85 each 		35,835
Filed 2023-06-02 17:26
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-293,874.75
-29,835 vol
$9.85 each 		1,304,000
Filed 2023-06-02 17:13
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-462,360
-12,000 vol
$38.53 each 		6,000
Filed 2023-06-02 17:11
Tx date 2023-05-30 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-758,100
-19,000 vol
$39.90 each 		18,000
Filed 2023-06-02 17:09
Tx date 2023-05-30 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-695,571.78
-18,006 vol
$38.63 each 		37,000
Filed 2023-05-26 19:38
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-58,376.43
-1,407 vol
$41.49 each 		31,302
Filed 2023-05-26 19:37
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,171 vol 		32,709
Filed 2023-05-26 19:36
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+6,172 vol 		33,880
Filed 2023-05-26 19:35
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-545,215.23
-13,179 vol
$41.37 each 		27,708
Filed 2023-05-26 19:35
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-3,902 vol 		40,887
Filed 2023-05-26 19:34
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+20,576 vol 		44,789
Filed 2023-05-26 19:33
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-707,339.36
-17,069 vol
$41.44 each 		24,213
Filed 2023-05-26 19:31
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-7,310 vol 		41,282
Filed 2023-05-26 19:30
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+42,592 vol 		48,592
Filed 2023-05-26 19:28
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-60,794.20
-6,172 vol
$9.85 each 		1,610,000
Filed 2023-05-26 19:25
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-202,673.60
-20,576 vol
$9.85 each 		1,616,172
Filed 2023-05-26 19:19
Tx date 2023-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-402,068.48
-42,592 vol
$9.44 each 		1,636,748
Filed 2023-03-24 19:31
Tx date 2023-03-24 		$XENE
Xenon Pharmaceuticals Inc. 		Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-24,507
-700 vol
$35.01 each 		0
Filed 2023-03-14 17:16
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+45,000 vol 		180,000
Filed 2023-03-14 17:06
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+120,000 vol 		395,000
Filed 2023-03-14 17:04
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+120,000 vol 		398,334
Filed 2023-03-14 17:01
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+90,000 vol 		350,000
Filed 2023-03-14 16:59
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+75,000 vol 		310,000
Filed 2023-03-14 16:57
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+75,000 vol 		442,141
Filed 2023-03-14 16:53
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+380,000 vol 		1,679,340
Filed 2023-03-09 19:02
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-304,459.48
-8,242 vol
$36.94 each 		55,006
Filed 2023-03-09 19:01
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,618 vol 		63,248
Filed 2023-03-09 19:01
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+30,864 vol 		64,866
Filed 2023-03-09 19:00
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-406,739.90
-10,990 vol
$37.01 each 		34,002
Filed 2023-03-09 18:59
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-2,160 vol 		44,992
Filed 2023-03-09 18:58
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+41,152 vol 		47,152
Filed 2023-03-09 18:55
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-79,937.76
-30,864 vol
$2.59 each 		1,333,835
Filed 2023-03-09 18:54
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-110,287.36
-41,152 vol
$2.68 each 		1,364,699
Filed 2022-12-13 16:36
Tx date 2022-12-12 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,239
+3,086 vol
$2.67 each 		69,905
Filed 2022-12-13 16:35
Tx date 2022-12-12 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-8,239.62
-3,086 vol
$2.67 each 		87,550
Filed 2022-11-28 20:53
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-67,390.3607
-1,937 vol
$34.79 each 		23,573
Filed 2022-11-28 20:52
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-120 vol 		25,510
Filed 2022-11-28 20:51
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$5,512
+2,057 vol
$2.68 each 		25,630
Filed 2022-11-28 20:49
Tx date 2022-11-25 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-5,512.76
-2,057 vol
$2.68 each 		92,488
Filed 2022-11-28 20:46
Tx date 2022-11-23 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-70,609.6105
-2,057 vol
$34.33 each 		23,573
Filed 2022-11-09 17:19
Tx date 2022-11-07 		$XENE
Xenon Pharmaceuticals Inc. 		DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+135,000 vol 		135,000
Filed 2022-11-09 17:16
Tx date 2022-11-07 		$XENE
Xenon Pharmaceuticals Inc. 		DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-09-07 16:42
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-607,597.35
-15,355 vol
$39.57 each 		0
Filed 2022-09-07 16:41
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-3,293 vol 		15,355
Filed 2022-09-07 16:40
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+6,511 vol 		18,648
Filed 2022-09-07 16:40
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+2,292 vol 		12,137
Filed 2022-09-07 16:39
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+813 vol 		9,845
Filed 2022-09-07 16:38
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+32 vol 		9,032
Filed 2022-09-07 16:38
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+9,000 vol 		9,000
Filed 2022-09-07 16:37
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-09-07 16:35
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-30,927.25
-6,511 vol
$4.75 each 		278,334
Filed 2022-09-07 16:35
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,105.20
-2,292 vol
$3.10 each 		284,845
Filed 2022-09-07 16:33
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-6,829.20
-813 vol
$8.40 each 		287,137
Filed 2022-09-07 16:32
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-239.68
-32 vol
$7.49 each 		287,950
Filed 2022-09-07 16:30
Tx date 2022-09-02 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-84,960
-9,000 vol
$9.44 each 		287,982
Filed 2022-09-02 17:36
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-340,508.80
-8,776 vol
$38.80 each 		16,796
Filed 2022-09-02 17:35
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,334,967.09
-35,103 vol
$38.03 each 		25,572
Filed 2022-09-02 17:34
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-6,121 vol 		60,675
Filed 2022-09-02 17:33
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+50,000 vol 		66,796
Filed 2022-09-02 17:32
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-823,546.64
-21,352 vol
$38.57 each 		16,796
Filed 2022-09-02 17:31
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,572 vol 		38,148
Filed 2022-09-02 17:30
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+5,000 vol 		39,720
Filed 2022-09-02 17:29
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+17,488 vol 		34,720
Filed 2022-09-02 17:26
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-237,500
-50,000 vol
$4.75 each 		367,141
Filed 2022-09-02 17:22
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-23,750
-5,000 vol
$4.75 each 		417,141
Filed 2022-09-02 17:21
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-46,692.96
-17,488 vol
$2.67 each 		422,141
Filed 2022-08-16 18:06
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-846,125
-21,875 vol
$38.68 each 		10,000
Filed 2022-08-16 18:06
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,365,853.44
-35,868 vol
$38.08 each 		31,875
Filed 2022-08-16 18:05
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-7,257 vol 		67,743
Filed 2022-08-16 18:03
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+45,000 vol 		75,000
Filed 2022-08-16 18:03
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+20,000 vol 		30,000
Filed 2022-08-16 18:01
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-213,750
-45,000 vol
$4.75 each 		235,000
Filed 2022-08-16 18:00
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-62,000
-20,000 vol
$3.10 each 		280,000
Filed 2022-08-16 17:54
Tx date 2022-08-16 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-777,400
-20,000 vol
$38.87 each 		6,000
Filed 2022-08-16 17:53
Tx date 2022-08-16 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,227,500.82
-32,058 vol
$38.29 each 		26,000
Filed 2022-08-16 17:53
Tx date 2022-08-15 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,281,649.92
-33,942 vol
$37.76 each 		58,058
Filed 2022-08-16 17:52
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-39,150
-1,000 vol
$39.15 each 		92,000
Filed 2022-08-16 17:51
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,814,200
-47,000 vol
$38.60 each 		93,000
Filed 2022-08-16 17:50
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,635,247.85
-43,135 vol
$37.91 each 		140,000
Filed 2022-06-29 19:04
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		38,000
Filed 2022-06-29 19:02
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Machado, Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		48,000
Filed 2022-06-29 18:58
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		76,644
Filed 2022-06-29 18:56
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		1,405,851
Filed 2022-06-29 18:53
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		94,545
Filed 2022-06-29 18:45
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		80,144
Filed 2022-06-29 18:42
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		90,636
Filed 2022-05-25 11:42
Tx date 2022-05-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
+15,000 vol 		15,000
Filed 2022-05-25 11:41
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-25 10:41
Tx date 2022-05-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-15,000 vol 		0
Filed 2022-03-14 17:12
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+125,000 vol 		275,000
Filed 2022-03-14 17:11
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+125,000 vol 		296,982
Filed 2022-03-14 17:08
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		260,000
Filed 2022-03-14 16:39
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		300,000
Filed 2022-03-14 16:36
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+75,000 vol 		439,629
Filed 2022-03-14 16:34
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		1,387,851
Filed 2022-03-14 16:30
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+400,000 vol 		1,299,340
Filed 2022-03-08 22:04
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,250
-2,500 vol
$30.50 each 		183,135
Filed 2022-03-08 22:03
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,375
-2,500 vol
$30.55 each 		185,635
Filed 2022-03-08 22:02
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-75,500
-2,500 vol
$30.20 each 		188,135
Filed 2022-03-08 22:02
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-75,250
-2,500 vol
$30.10 each 		190,635
Filed 2022-03-08 22:01
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-77,000
-2,500 vol
$30.80 each 		193,135
Filed 2022-03-08 22:01
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-62,760.60
-2,051 vol
$30.60 each 		195,635
Filed 2022-03-08 22:00
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,375
-2,500 vol
$30.55 each 		197,686
Filed 2022-03-08 22:00
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-228,750
-7,500 vol
$30.50 each 		200,186
Filed 2022-03-08 21:59
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,300
-2,500 vol
$30.52 each 		207,686
Filed 2022-03-08 21:59
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-137,467.04
-4,516 vol
$30.44 each 		210,186
Filed 2022-03-08 21:58
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-137,512.20
-4,516 vol
$30.45 each 		214,702
Filed 2022-03-08 21:57
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-137,723.33
-4,517 vol
$30.49 each 		219,218
Filed 2022-03-08 21:57
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-154,132.20
-5,037 vol
$30.60 each 		223,735
Filed 2022-03-08 21:56
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,990 vol 		228,772
Filed 2022-03-08 21:55
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$76,954
+20,576 vol
$3.74 each 		230,762
Filed 2022-03-08 21:55
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-146,474.08
-4,793 vol
$30.56 each 		210,186
Filed 2022-03-08 21:54
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-138,951.12
-4,532 vol
$30.66 each 		214,979
Filed 2022-03-08 21:53
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-963 vol 		219,511
Filed 2022-03-08 21:53
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$38,477
+10,288 vol
$3.74 each 		220,474
Filed 2022-03-08 21:52
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-76,954.24
-20,576 vol
$3.74 each 		1,362,851
Filed 2022-03-08 21:51
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-38,477.12
-10,288 vol
$3.74 each 		1,383,427
Filed 2022-03-08 20:28
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-948,205.92
-31,048 vol
$30.54 each 		10,000
Filed 2022-03-08 20:28
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-55,269.10
-1,805 vol
$30.62 each 		41,048
Filed 2022-03-08 20:27
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-8,952 vol 		42,853
Filed 2022-03-08 20:26
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$270,400
+40,000 vol
$6.76 each 		51,805
Filed 2022-03-08 20:25
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-695 vol 		11,805
Filed 2022-03-08 20:24
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$21,000
+2,500 vol
$8.40 each 		12,500
Filed 2022-03-08 20:23
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-563,918.85
-18,315 vol
$30.79 each 		10,000
Filed 2022-03-08 20:22
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-6,685 vol 		28,315
Filed 2022-03-08 20:21
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+25,000 vol 		35,000
Filed 2022-03-08 20:21
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-270,400
-40,000 vol
$6.76 each 		235,000
Filed 2022-03-08 20:20
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-21,000
-2,500 vol
$8.40 each 		275,000
Filed 2022-03-08 20:19
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-210,000
-25,000 vol
$8.40 each 		277,500
Filed 2022-03-08 20:14
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-151,150
-5,000 vol
$30.23 each 		17,232
Filed 2022-03-08 20:13
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-155,250
-5,000 vol
$31.05 each 		22,232
Filed 2022-03-08 20:12
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-150,750
-5,000 vol
$30.15 each 		27,232
Filed 2022-03-08 20:11
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-205,057.60
-6,710 vol
$30.56 each 		32,232
Filed 2022-03-08 20:10
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+6,172 vol 		38,942
Filed 2022-03-08 20:09
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-696 vol 		32,770
Filed 2022-03-08 20:07
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$4,615
+1,234 vol
$3.74 each 		33,466
Filed 2022-03-08 20:05
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-23,083.28
-6,172 vol
$3.74 each 		364,629
Filed 2022-03-08 20:05
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-4,615.16
-1,234 vol
$3.74 each 		370,801
Filed 2022-01-21 17:09
Tx date 2022-01-21 		$XENE
Xenon Pharmaceuticals Inc. 		Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$20,167
+700 vol
$28.81 each 		700
Filed 2022-01-21 17:07
Tx date 2021-08-23 		$XENE
Xenon Pharmaceuticals Inc. 		Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-17 16:17
Tx date 2021-12-15 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		66,819
Filed 2021-12-17 16:16
Tx date 2021-12-15 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-11,541.64
-3,086 vol
$3.74 each 		72,636
Filed 2021-12-10 16:39
Tx date 2021-12-08 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		25,630
Filed 2021-12-10 16:36
Tx date 2021-12-08 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		76,545
Filed 2021-12-07 16:32
Tx date 2021-12-06 		$XENE
Xenon Pharmaceuticals Inc. 		Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$97,600
+4,000 vol
$24.40 each 		4,000
Filed 2021-12-07 16:22
Tx date 2020-08-17 		$XENE
Xenon Pharmaceuticals Inc. 		Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-11-16 20:58
Tx date 2021-11-15 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-550,060.81
-17,557 vol
$31.33 each 		210,186
Filed 2021-08-25 16:22
Tx date 2021-08-23 		$XENE
Xenon Pharmaceuticals Inc. 		Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+150,000 vol 		150,000
Filed 2021-08-25 16:20
Tx date 2021-08-23 		$XENE
Xenon Pharmaceuticals Inc. 		Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-09 19:31
Tx date 2021-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: David Patou (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
-100 vol 		0
Filed 2021-06-09 13:51
Tx date 2021-03-17 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: David Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,948
+100 vol
$19.49 each 		100
Filed 2021-06-09 13:43
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: David Patou (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-04 19:55
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		78,602
Filed 2021-06-03 21:57
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		58,644
Filed 2021-06-03 21:55
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Machado, Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		30,000
Filed 2021-06-03 21:52
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		65,844
Filed 2021-06-03 21:50
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		62,144
Filed 2021-06-03 21:40
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		75,722
Filed 2021-06-03 21:37
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		20,000
Filed 2021-06-03 21:35
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-03 18:46
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,320,000
+125,000 vol
$18.56 each 		899,340
Filed 2021-06-03 18:42
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,855,999
+100,000 vol
$18.56 each 		171,982
Filed 2021-06-03 18:40
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		71,982
Filed 2021-06-01 18:03
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-54,774.72
-2,912 vol
$18.81 each 		32,232
Filed 2021-06-01 18:01
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,345.55
-3,155 vol
$18.81 each 		35,144
Filed 2021-06-01 18:00
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-2,192 vol 		38,299
Filed 2021-06-01 18:00
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$50,018
+13,374 vol
$3.74 each 		40,491
Filed 2021-06-01 17:59
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-2,024 vol 		27,117
Filed 2021-06-01 17:59
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$46,170
+12,345 vol
$3.74 each 		29,141
Filed 2021-06-01 17:58
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-50,018.76
-13,374 vol
$3.74 each 		372,035
Filed 2021-06-01 17:57
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-46,170.30
-12,345 vol
$3.74 each 		385,409
Filed 2021-06-01 17:47
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-158,499.80
-8,485 vol
$18.68 each 		143,653
Filed 2021-06-01 17:46
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-48,201.51
-2,579 vol
$18.69 each 		152,138
Filed 2021-06-01 17:44
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-5,911 vol 		154,717
Filed 2021-06-01 17:43
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$134,669
+36,008 vol
$3.74 each 		160,628
Filed 2021-06-01 17:42
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-507 vol 		124,620
Filed 2021-06-01 17:42
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		125,127
Filed 2021-06-01 17:41
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-134,669.92
-36,008 vol
$3.74 each 		75,187
Filed 2021-06-01 17:39
Tx date 2021-05-27 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-11,541.64
-3,086 vol
$3.74 each 		111,195
Filed 2021-05-26 16:25
Tx date 2021-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-5,076 vol 		227,743
Filed 2021-05-26 16:23
Tx date 2021-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$84,647
+22,633 vol
$3.74 each 		232,819
Filed 2021-05-26 16:22
Tx date 2021-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-84,647.42
-22,633 vol
$3.74 each 		1,393,715
Filed 2021-05-20 21:07
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$18,878
+5,144 vol
$3.67 each 		77,942
Filed 2021-05-20 21:06
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-18,878.48
-5,144 vol
$3.67 each 		80,771
Filed 2021-05-20 21:05
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$3,772
+1,028 vol
$3.67 each 		72,798
Filed 2021-05-20 21:04
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-3,772.76
-1,028 vol
$3.67 each 		85,915
Filed 2021-05-20 21:03
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,960
+2,057 vol
$3.87 each 		71,770
Filed 2021-05-20 21:02
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,960.59
-2,057 vol
$3.87 each 		86,943
Filed 2021-05-20 20:53
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$13,475
+3,500 vol
$3.85 each 		116,206
Filed 2021-05-20 20:50
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-13,475
-3,500 vol
$3.85 each 		55,844
Filed 2021-03-15 17:10
Tx date 2021-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+60,000 vol 		160,000
Filed 2021-03-15 17:06
Tx date 2021-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		774,340
Filed 2021-03-15 17:02
Tx date 2021-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		302,500
Filed 2021-03-15 16:58
Tx date 2021-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+225,000 vol 		1,416,348
Filed 2021-03-15 16:52
Tx date 2021-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		397,754
Filed 2021-02-18 20:59
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$82,406
+30,864 vol
$2.67 each 		92,076
Filed 2021-02-18 20:58
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-30,864 vol 		0
Filed 2021-02-18 20:56
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$38,477
+10,288 vol
$3.74 each 		61,212
Filed 2021-02-18 20:54
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-10,288 vol 		30,864
Filed 2021-02-18 20:49
Tx date 2021-02-16 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$13,734
+5,144 vol
$2.67 each 		112,706
Filed 2021-02-18 20:47
Tx date 2021-02-16 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-13,734.48
-5,144 vol
$2.67 each 		59,344
Filed 2020-12-15 16:49
Tx date 2020-12-15 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		63,733
Filed 2020-12-15 16:48
Tx date 2020-12-15 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-11,541.64
-3,086 vol
$3.74 each 		65,722
Filed 2020-11-05 20:39
Tx date 2020-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Machado, Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		20,000
Filed 2020-11-05 20:34
Tx date 2020-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Machado, Patrick
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-29 17:06
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift 		$-38,477.12
-10,288 vol
$3.74 each 		69,713
Filed 2020-10-29 16:57
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$19,238
+5,144 vol
$3.74 each 		80,001
Filed 2020-10-29 16:56
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-19,238.56
-5,144 vol
$3.74 each 		89,000
Filed 2020-10-29 16:55
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$19,238
+5,144 vol
$3.74 each 		74,857
Filed 2020-10-29 16:54
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-19,238.56
-5,144 vol
$3.74 each 		94,144
Filed 2020-10-29 16:48
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		23,573
Filed 2020-10-29 16:46
Tx date 2020-10-28 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		68,602
Filed 2020-08-25 20:20
Tx date 2020-08-20 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Holder: Kanya Adam (Indirect Ownership)
Common Shares
97 - Other
-16,460 vol 		0
Filed 2020-08-24 18:47
Tx date 2020-08-20 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-45,000 vol 		210,186
Filed 2020-08-17 19:39
Tx date 2020-08-17 		$XENE
Xenon Pharmaceuticals Inc. 		Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		100,000
Filed 2020-08-17 19:35
Tx date 2020-08-17 		$XENE
Xenon Pharmaceuticals Inc. 		Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-06-10 18:58
Tx date 2020-06-09 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$19,238
+5,144 vol
$3.74 each 		69,713
Filed 2020-06-10 18:57
Tx date 2020-06-09 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-19,238.56
-5,144 vol
$3.74 each 		99,288
Filed 2020-06-02 20:38
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,630 vol 		16,796
Filed 2020-06-02 20:37
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$30,780
+8,230 vol
$3.74 each 		18,426
Filed 2020-06-02 20:35
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-30,780.20
-8,230 vol
$3.74 each 		332,754
Filed 2020-06-02 20:28
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		114,281
Filed 2020-06-02 20:24
Tx date 2020-05-29 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		122,041
Filed 2020-06-02 20:23
Tx date 2020-05-29 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-11,541.64
-3,086 vol
$3.74 each 		104,281
Filed 2020-06-02 20:07
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		104,432
Filed 2020-06-02 20:05
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		48,644
Filed 2020-06-02 20:03
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		70,659
Filed 2020-06-02 19:59
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		64,488
Filed 2020-06-02 19:51
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		35,000
Filed 2020-06-02 19:48
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		52,144
Filed 2020-06-02 19:41
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		68,808
Filed 2020-06-02 19:26
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-43,290
-3,000 vol
$14.43 each 		255,186
Filed 2020-06-02 19:24
Tx date 2020-05-29 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-69,950
-5,000 vol
$13.99 each 		258,186
Filed 2020-05-28 20:30
Tx date 2020-05-26 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,108 vol 		263,186
Filed 2020-05-28 20:28
Tx date 2020-05-26 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$23,083
+6,172 vol
$3.74 each 		264,294
Filed 2020-05-28 20:26
Tx date 2020-05-26 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-23,083.28
-6,172 vol
$3.74 each 		1,191,348
Filed 2020-03-16 16:49
Tx date 2020-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		180,000
Filed 2020-03-16 16:43
Tx date 2020-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		237,500
Filed 2020-03-16 16:37
Tx date 2020-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+280,000 vol 		1,197,520
Filed 2020-03-16 16:33
Tx date 2020-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+145,000 vol 		674,340
Filed 2020-03-16 16:26
Tx date 2020-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		340,984
Filed 2020-01-14 15:11
Tx date 2020-01-13 		$XENE
Xenon Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		25,000
Filed 2020-01-14 15:07
Tx date 2020-01-13 		$XENE
Xenon Pharmaceuticals Inc. 		Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-17 17:22
Tx date 2019-12-16 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-11,541.64
-3,086 vol
$3.74 each 		58,808
Filed 2019-12-17 17:19
Tx date 2019-12-16 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		60,647
Filed 2019-12-06 17:25
Tx date 2019-12-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		60,659
Filed 2019-12-06 17:23
Tx date 2019-12-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		21,516
Filed 2019-11-22 16:20
Tx date 2019-11-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		94,432
Filed 2019-11-22 16:17
Tx date 2019-11-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift 		$-7,693.18
-2,057 vol
$3.74 each 		64,569
Filed 2019-11-22 16:16
Tx date 2019-11-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		66,626
Filed 2019-11-22 16:12
Tx date 2019-11-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-19,238.56
-5,144 vol
$3.74 each 		96,489
Filed 2019-11-22 16:10
Tx date 2019-11-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift 		$-19,238.56
-5,144 vol
$3.74 each 		64,569
Filed 2019-11-22 16:08
Tx date 2019-11-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$19,238
+5,144 vol
$3.74 each 		69,713
Filed 2019-09-24 18:26
Tx date 2019-09-20 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-98,856.45
-10,395 vol
$9.51 each 		258,122
Filed 2019-09-20 16:24
Tx date 2019-09-20 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-48,884.34
-5,206 vol
$9.39 each 		118,955
Filed 2019-09-20 16:23
Tx date 2019-09-19 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-70,452
-7,600 vol
$9.27 each 		124,161
Filed 2019-09-20 13:02
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$424,800
+45,000 vol
$9.44 each 		275,984
Filed 2019-09-19 20:21
Tx date 2019-09-18 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-40,535.04
-4,368 vol
$9.28 each 		131,761
Filed 2019-09-19 20:20
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,243.08
-5,069 vol
$9.32 each 		136,129
Filed 2019-09-19 20:18
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		107,367
Filed 2019-09-19 19:38
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,643,200
+280,000 vol
$9.44 each 		975,132
Filed 2019-09-19 19:35
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$32,362
+8,653 vol
$3.74 each 		268,517
Filed 2019-09-19 19:34
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-3,692 vol 		917,520
Filed 2019-09-19 19:33
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-32,362.22
-8,653 vol
$3.74 each 		921,212
Filed 2019-09-19 19:32
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,272
+6,490 vol
$3.74 each 		259,864
Filed 2019-09-19 19:31
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-2,769 vol 		929,865
Filed 2019-09-19 19:30
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-24,272.60
-6,490 vol
$3.74 each 		932,634
Filed 2019-09-19 19:29
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$94,393
+25,239 vol
$3.74 each 		253,374
Filed 2019-09-19 19:27
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-10,769 vol 		939,124
Filed 2019-09-19 19:26
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-94,393.86
-25,239 vol
$3.74 each 		949,893
Filed 2019-09-19 17:24
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$67,091
+17,939 vol
$3.74 each 		141,198
Filed 2019-09-19 17:23
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-7,781 vol 		92,367
Filed 2019-09-19 17:22
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-67,091.86
-17,939 vol
$3.74 each 		100,148
Filed 2019-09-19 17:21
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,048
+2,152 vol
$3.74 each 		123,259
Filed 2019-09-19 17:19
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-934 vol 		118,087
Filed 2019-09-19 17:18
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-8,048.48
-2,152 vol
$3.74 each 		119,021
Filed 2019-09-19 17:16
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,048
+2,152 vol
$3.74 each 		121,107
Filed 2019-09-19 17:15
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-934 vol 		121,173
Filed 2019-09-19 17:13
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-8,048.48
-2,152 vol
$3.74 each 		122,107
Filed 2019-09-19 15:56
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		42,144
Filed 2019-09-19 15:22
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$613,600
+65,000 vol
$9.44 each 		115,000
Filed 2019-09-19 15:17
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$377,600
+40,000 vol
$9.44 each 		172,500
Filed 2019-09-19 15:13
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,274,400
+135,000 vol
$9.44 each 		529,340
Filed 2019-09-19 15:07
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		54,488
Filed 2019-09-19 14:50
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		62,716
Filed 2019-09-19 14:34
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		45,230
Filed 2019-09-19 14:17
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		38,644
Filed 2019-09-19 14:05
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		101,633
Filed 2019-09-18 21:29
Tx date 2019-09-13 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-214.1806
-23 vol
$9.31 each 		57,561
Filed 2019-09-18 21:24
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		61,894
Filed 2019-09-18 21:07
Tx date 2019-09-13 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-214.1806
-23 vol
$9.31 each
Filed 2019-09-18 20:24
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$16,096
+4,304 vol
$3.74 each 		10,196
Filed 2019-09-18 20:17
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-1,868 vol 		230,984
Filed 2019-09-18 20:15
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-16,096.96
-4,304 vol
$3.74 each 		232,852
Filed 2019-05-22 20:34
Tx date 2019-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		86,633
Filed 2019-05-22 20:31
Tx date 2019-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		64,569
Filed 2019-03-20
Tx date 2019-03-19 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$76,954
+20,576 vol
$3.74 each 		50,924
Filed 2019-03-20
Tx date 2019-03-19 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-20,576 vol 		41,152
Filed 2019-03-14
Tx date 2019-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Sandra Hayden (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
+17,337 vol 		114,403
Filed 2019-03-14
Tx date 2019-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-24,045 vol
Filed 2019-03-14
Tx date 2019-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-24,045 vol 		107,562
Filed 2018-12-26
Tx date 2018-12-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-5,000 vol 		62,512
Filed 2018-12-18
Tx date 2018-12-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,693
+2,057 vol
$3.74 each 		19,459
Filed 2018-12-18
Tx date 2018-12-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,693.18
-2,057 vol
$3.74 each 		47,716
Filed 2018-12-13
Tx date 2018-12-11 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-15,390.10
-4,115 vol
$3.74 each 		160,915
Filed 2018-12-13
Tx date 2018-12-11 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,644 vol 		6,550
Filed 2018-12-13
Tx date 2018-12-11 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$15,390
+4,115 vol
$3.74 each 		8,194
Filed 2018-12-10
Tx date 2018-12-06 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-11,541.64
-3,086 vol
$3.74 each 		46,894
Filed 2018-12-10
Tx date 2018-12-06 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		57,584
Filed 2018-06-22
Tx date 2018-06-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,144 vol 		88,690
Filed 2018-06-22
Tx date 2018-06-21 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$38,477
+10,288 vol
$3.74 each 		54,498
Filed 2018-06-22
Tx date 2018-06-21 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-10,288 vol 		49,980
Filed 2018-06-22
Tx date 2018-06-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$46,170
+12,345 vol
$3.74 each 		67,512
Filed 2018-06-22
Tx date 2018-06-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,144 vol 		95,891
Filed 2018-06-22
Tx date 2018-06-21 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-2,057 vol 		93,834
Filed 2018-06-15
Tx date 2018-06-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,374 vol 		52,629
Filed 2018-06-15
Tx date 2018-06-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-2,856 vol 		49,773
Filed 2018-06-15
Tx date 2018-06-14 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$20,098
+5,374 vol
$3.74 each 		17,402
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		101,035
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		60,268
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		27,144
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		39,488
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		124,259
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		58,003
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		30,230
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		23,644
Filed 2018-03-20
Tx date 2018-03-19 		$XENE
Xenon Pharmaceuticals Inc. 		Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+50,000 vol 		50,000
Filed 2018-03-20
Tx date 2018-03-19 		$XENE
Xenon Pharmaceuticals Inc. 		Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2018-03-19 		$XENE
Xenon Pharmaceuticals Inc. 		Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-15 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$4,330
+1,158 vol
$3.74 each 		5,892
Filed 2018-03-16
Tx date 2018-03-15 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-4,330.92
-1,158 vol
$3.74 each 		239,084
Filed 2018-03-16
Tx date 2018-03-15 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-1,928 vol 		237,156
Filed 2018-03-16
Tx date 2018-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		118,955
Filed 2018-03-16
Tx date 2018-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-11,541.64
-3,086 vol
$3.74 each 		109,259
Filed 2018-03-14
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$38,477
+10,288 vol
$3.74 each 		228,135
Filed 2018-03-14
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-38,477.12
-10,288 vol
$3.74 each 		695,132
Filed 2018-03-13
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+105,000 vol 		394,340
Filed 2018-03-13
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+55,000 vol 		240,242
Filed 2018-03-13
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+45,000 vol 		132,500
Filed 2018-03-13
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		705,420
Filed 2018-03-13
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		165,030
Filed 2018-03-01
Tx date 2018-02-22 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-29,580 vol 		131,607
Filed 2018-03-01
Tx date 2018-02-22 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Sandra Hayden (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
+21,180 vol 		97,066
Filed 2018-02-14
Tx date 2018-02-12 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$15,255
+4,079 vol
$3.74 each 		4,079
Filed 2018-02-14
Tx date 2018-02-12 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-4,079 vol 		125,030
Filed 2018-02-14
Tx date 2018-02-12 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-22,669 vol 		129,109
Filed 2018-02-14
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-26
Tx date 2017-08-14 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-12,345 vol 		112,345
Filed 2018-01-04
Tx date 2018-01-01 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-3,497 vol 		43,003
Filed 2018-01-04
Tx date 2018-01-01 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-6,583 vol 		86,035
Filed 2018-01-04
Tx date 2018-01-01 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-3,497 vol 		45,268
Filed 2017-11-16
Tx date 2017-11-15 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$33,280
+15,000 vol
$2.22 each 		44,210
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,000 vol 		151,778
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,000 vol 		565,420
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,000 vol 		185,242
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,000 vol 		159,585
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		87,500
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		289,340
Filed 2017-09-25
Tx date 2017-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$23,600
+8,000 vol
$2.95 each 		29,210
Filed 2017-09-25
Tx date 2017-09-21 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,900
+2,000 vol
$2.95 each 		21,210
Filed 2017-08-21
Tx date 2017-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,301
+6,312 vol
$2.90 each 		19,210
Filed 2017-08-21
Tx date 2017-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,995
+1,000 vol
$3.00 each 		1,000
Filed 2017-08-21
Tx date 2016-04-04 		$XENE
Xenon Pharmaceuticals Inc. 		Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-21
Tx date 2017-08-17 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$60.95
+23 vol
$2.65 each 		12,898
Filed 2017-08-17
Tx date 2017-08-15 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$24,824
+10,000 vol
$2.48 each 		10,000
Filed 2017-08-17
Tx date 2016-02-08 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-15
Tx date 2016-09-27 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-15
Tx date 2017-08-14 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$140,770
+50,000 vol
$2.82 each 		50,000
Filed 2017-08-14
Tx date 2017-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$19,950
+7,000 vol
$2.85 each 		7,000
Filed 2017-08-14
Tx date 2017-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$14,225
+5,000 vol
$2.85 each 		6,000
Filed 2017-08-14
Tx date 2017-08-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$41,247
+15,000 vol
$2.75 each 		161,187
Filed 2017-08-14
Tx date 2017-08-11 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$42,267
+15,000 vol
$2.82 each 		15,000
Filed 2017-08-14
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-14
Tx date 2017-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$29,000
+10,000 vol
$2.90 each 		14,300
Filed 2017-08-14
Tx date 2017-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$20,835
+7,500 vol
$2.78 each 		12,500
Filed 2017-08-14
Tx date 2017-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$17,400
+6,000 vol
$2.90 each 		217,847
Filed 2017-08-14
Tx date 2015-03-16 		$XENE
Xenon Pharmaceuticals Inc. 		Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-10
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-10
Tx date 2017-08-08 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$15,002
+5,000 vol
$3.00 each 		5,000
Filed 2017-06-20
Tx date 2017-06-19 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift 		$-3,844.72
-1,028 vol
$3.74 each 		55,167
Filed 2017-06-20
Tx date 2017-06-19 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$3,844
+1,028 vol
$3.74 each 		56,195
Filed 2017-06-20
Tx date 2017-06-19 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-3,844.72
-1,028 vol
$3.74 each 		92,618
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		124,690
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		15,230
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		8,644
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		24,488
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		12,144
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		48,765
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$4,812
+1,250 vol
$3.85 each 		93,646
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		92,396
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		46,500
Filed 2017-05-16
Tx date 2017-05-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$2,662
+712 vol
$3.74 each 		4,734
Filed 2017-05-16
Tx date 2017-05-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-2,662.88
-712 vol
$3.74 each 		175,587
Filed 2017-05-16
Tx date 2017-05-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-1,345 vol 		174,242
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-3,086 vol 		61,728
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-4,629 vol 		64,814
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-4,115 vol 		69,443
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,144 vol 		20,988
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-25,720 vol 		26,132
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-18,004 vol 		51,852
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		30,348
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$17,312
+4,629 vol
$3.74 each 		27,262
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$15,390
+4,115 vol
$3.74 each 		22,633
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$19,238
+5,144 vol
$3.74 each 		146,187
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$96,192
+25,720 vol
$3.74 each 		141,043
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$67,334
+18,004 vol
$3.74 each 		115,323
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		140,778
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		55,000
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+27,500 vol 		176,299
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		554,420
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+75,000 vol 		264,340
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+27,500 vol 		148,585
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+27,500 vol 		67,500
Filed 2017-01-27
Tx date 2017-01-26 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-7,201 vol 		55,167
Filed 2016-12-19
Tx date 2016-12-15 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-235,500
-30,000 vol
$7.85 each 		115,869
Filed 2016-12-13
Tx date 2016-12-12 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$26,931
+7,201 vol
$3.74 each 		62,368
Filed 2016-12-13
Tx date 2016-12-12 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-53,867.22
-14,403 vol
$3.74 each 		88,896
Filed 2016-12-13
Tx date 2016-12-12 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift 		$-26,935.48
-7,202 vol
$3.74 each 		62,368
Filed 2016-12-13
Tx date 2016-12-12 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$26,935
+7,202 vol
$3.74 each 		69,570
Filed 2016-12-08
Tx date 2016-12-06 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-46,170.30
-12,345 vol
$3.74 each 		43,000
Filed 2016-12-08
Tx date 2016-12-06 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$29,703
+7,942 vol
$3.74 each 		12,028
Filed 2016-12-02
Tx date 2016-12-01 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-46,170.30
-12,345 vol
$3.74 each 		45,265
Filed 2016-12-02
Tx date 2016-12-01 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$29,684
+7,937 vol
$3.74 each 		12,875
Filed 2016-09-27
Tx date 2016-09-27 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-27
Tx date 2016-09-27 		$XENE
Xenon Pharmaceuticals Inc. 		Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+5,144 vol 		5,144
Filed 2016-08-23
Tx date 2016-08-19 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-91,337.638
-11,938 vol
$7.65 each 		145,869
Filed 2016-08-18
Tx date 2016-08-17 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-12,624
-1,600 vol
$7.89 each 		167,406
Filed 2016-08-18
Tx date 2016-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-73,912.30
-9,599 vol
$7.70 each 		157,807
Filed 2016-08-18
Tx date 2016-08-16 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-56,619.75
-6,863 vol
$8.25 each 		169,006
Filed 2016-08-02
Tx date 2016-07-29 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-12,345 vol 		414,420
Filed 2016-08-02
Tx date 2016-07-29 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$28,581
+7,642 vol
$3.74 each 		211,847
Filed 2016-06-28
Tx date 2016-06-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$6,100
+1,000 vol
$6.10 each 		1,000
Filed 2016-06-28
Tx date 2016-06-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$8,190
+1,300 vol
$6.30 each 		4,300
Filed 2016-06-28
Tx date 2016-06-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$12,500
+2,000 vol
$6.25 each 		3,000
Filed 2016-06-28
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-28
Tx date 2016-06-24 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,150
+1,000 vol
$6.15 each 		1,000
Filed 2016-06-28
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		57,610
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$9,225
+1,250 vol
$7.38 each 		103,299
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		102,049
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		11,730
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		55,345
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		121,190
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		69,856
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		8,644
Filed 2016-05-27
Tx date 2016-05-25 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$30,780
+8,230 vol
$3.74 each 		18,518
Filed 2016-05-27
Tx date 2016-05-25 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options 		$-30,780.20
-8,230 vol
$3.74 each 		73,558
Filed 2016-04-29
Tx date 2016-04-28 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
47 - Acquisition or disposition by gift 		$-5,770.82
-1,543 vol
$3.74 each 		98,549
Filed 2016-04-04
Tx date 2016-04-04 		$XENE
Xenon Pharmaceuticals Inc. 		Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+35,000 vol 		35,000
Filed 2016-04-04
Tx date 2016-04-04 		$XENE
Xenon Pharmaceuticals Inc. 		Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-11
Tx date 2016-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		121,085
Filed 2016-03-11
Tx date 2016-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		148,799
Filed 2016-03-11
Tx date 2016-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+50,000 vol 		426,765
Filed 2016-03-11
Tx date 2016-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		189,340
Filed 2016-03-11
Tx date 2016-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		120,778
Filed 2016-02-10
Tx date 2016-02-08 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		40,000
Filed 2016-02-10
Tx date 2016-02-08 		$XENE
Xenon Pharmaceuticals Inc. 		Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-21
Tx date 2015-12-18 		$XENE
Xenon Pharmaceuticals Inc. 		Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		149,340
Filed 2015-12-21
Tx date 2015-12-18 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+15,000 vol 		128,799
Filed 2015-12-21
Tx date 2015-12-18 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+15,000 vol 		101,085
Filed 2015-12-21
Tx date 2015-12-18 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		376,765
Filed 2015-12-21
Tx date 2015-12-18 		$XENE
Xenon Pharmaceuticals Inc. 		Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+15,000 vol 		95,778
Filed 2015-12-18
Tx date 2015-12-16 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-2,494.77
-411 vol
$6.07 each 		113,799
Filed 2015-12-18
Tx date 2015-12-16 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$1,104
+182 vol
$6.07 each 		4,022
Filed 2015-12-14
Tx date 2015-12-11 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$14,986
+2,469 vol
$6.07 each 		4,938
Filed 2015-12-14
Tx date 2015-12-11 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-14,986.83
-2,469 vol
$6.07 each 		54,110
Filed 2015-11-25
Tx date 2015-11-24 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-12,485.99
-2,057 vol
$6.07 each 		117,690
Filed 2015-11-25
Tx date 2015-11-24 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$6,446
+1,062 vol
$6.07 each 		175,869
Filed 2015-11-06
Tx date 2015-11-02 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
47 - Acquisition or disposition by gift 		$-30,598.87
-5,041 vol
$6.07 each 		100,092
Filed 2015-11-06
Tx date 2015-11-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-21,226.79
-3,497 vol
$6.07 each 		51,845
Filed 2015-11-06
Tx date 2015-11-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$9,359
+1,542 vol
$6.07 each 		4,086
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,198
+2,192 vol
$3.74 each 		21,245
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-7,973 vol 		86,870
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,115 vol 		94,843
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,703 vol 		97,958
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-6,172 vol 		101,661
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,144 vol 		107,833
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-1,028 vol 		112,977
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-785 vol 		86,085
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-411 vol 		116,062
Filed 2015-09-26
Tx date 2015-09-24 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-103,200
-12,000 vol
$8.60 each 		6,000
Filed 2015-09-26
Tx date 2015-09-23 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-36,080
-4,000 vol
$9.02 each 		18,000
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-57,370.17
-6,149 vol
$9.33 each 		22,000
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$1,650
+618 vol
$2.67 each 		28,149
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$16,783
+6,286 vol
$2.67 each 		27,531
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-2,057 vol 		114,005
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$1,292
+213 vol
$6.07 each 		6,316
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$5,411
+1,447 vol
$3.74 each 		7,763
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$2,704
+723 vol
$3.74 each 		8,486
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$13,535
+3,619 vol
$3.74 each 		12,105
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$16,242
+4,343 vol
$3.74 each 		16,448
Filed 2015-09-26
Tx date 2015-09-22 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$9,742
+2,605 vol
$3.74 each 		19,053
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$10,822
+1,783 vol
$6.07 each 		3,840
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-20,576 vol 		336,765
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$10,822
+1,783 vol
$6.07 each 		6,103
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,085 vol 		116,473
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,217
+1,189 vol
$6.07 each 		174,807
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-2,057 vol 		119,747
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$72,220
+11,898 vol
$6.07 each 		204,205
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,085 vol 		114,210
Filed 2015-06-19
Tx date 2015-06-17 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-9,366.01
-1,543 vol
$6.07 each 		105,133
Filed 2015-06-19
Tx date 2015-06-17 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$9,366
+1,543 vol
$6.07 each 		55,167
Filed 2015-05-25
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+5,144 vol 		5,144
Filed 2015-05-25
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-05-08
Tx date 2015-01-07 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$15,442
+2,544 vol
$6.07 each 		2,544
Filed 2015-05-08
Tx date 2015-01-07 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$21,226
+3,497 vol
$6.07 each
Filed 2015-05-08
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Evans, Johnston Livingston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		8,230
Filed 2015-05-08
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Evans, Johnston Livingston
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		5,144
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,028 vol 		106,676
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		55,342
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		121,804
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		66,356
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		56,579
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		105,648
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		8,230
Filed 2015-05-05
Tx date 2015-04-30 		$XENE
Xenon Pharmaceuticals Inc. 		Stein, Evan Albert
4 - Director of Issuer
Holder: Stein Family, LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
+909,619 vol 		910,586
Filed 2015-05-05
Tx date 2015-04-30 		$XENE
Xenon Pharmaceuticals Inc. 		Stein, Evan Albert
4 - Director of Issuer
Holder: Lipoterx Ltd. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
-1,038,964 vol 		0
Filed 2015-05-05
Tx date 2015-04-30 		$XENE
Xenon Pharmaceuticals Inc. 		Stein, Evan Albert
4 - Director of Issuer
Holder: Lipoterx Holdings, LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
+4,172 vol 		4,172
Filed 2015-05-05
Tx date 2014-11-05 		$XENE
Xenon Pharmaceuticals Inc. 		Stein, Evan Albert
4 - Director of Issuer
Holder: Lipoterx Holdings, LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report